Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?

Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?

Item
http://www.wikidata.org/entity/Q33776187
Adverse Effects of GLP-1 Receptor AgonistsPitavastatin and carbohydrate metabolism: what is the evidence?Dapagliflozin in patients with type 2 diabetes mellitus.Comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicenter clinical trial in Indian population.Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy.The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].Safety considerations with fenofibrate/simvastatin combination.Acid-base and electrolyte disorders associated with the use of antidiabetic drugs.Effects of sodium-glucose co-transporter 2 inhibitors on metabolism: unanswered questions and controversies.Paraoxonase 1 Activity, Lipid Profile, and Atherogenic Indexes Status in Coronary Heart Disease.SGLT2 inhibitors: are they safe?New Fixed-Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High-Risk Patients with Mixed Dyslipidemia Versus Monotherapies.
P2860

Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?

Item
http://www.wikidata.org/entity/Q33776187
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Does combination therapy with ...... therogenic mixed dyslipidemia?
@ast
Does combination therapy with ...... therogenic mixed dyslipidemia?
@en
type
label
Does combination therapy with ...... therogenic mixed dyslipidemia?
@ast
Does combination therapy with ...... therogenic mixed dyslipidemia?
@en
prefLabel
Does combination therapy with ...... therogenic mixed dyslipidemia?
@ast
Does combination therapy with ...... therogenic mixed dyslipidemia?
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Does combination therapy with ...... therogenic mixed dyslipidemia?
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932